STOCK TITAN
  1. Home
  2. Sec-filings
  3. TAK
  4. [Form 4] TAKEDA PHARMACEUTICAL CO LTD Insider Trading Activity

Takeda (TAK) director Masami Iijima reports RSU grant and tax obligation awards

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Takeda Pharmaceutical director Masami Iijima reported compensation-related equity activity. On July 1, he received a grant of 1,800 Ordinary Shares as a restricted stock unit award, increasing his direct holdings to 14,601 shares. The RSUs vest on June 1, 2029.

He also received 1,937 Tax Obligation Awards, each economically equivalent to one Ordinary Share and payable in cash at vesting primarily to cover tax obligations at the then-current market price. Separately, 2,152 Tax Obligation Awards tied to previously vested shares were disposed to the issuer on July 10 at a weighted average price of JPY 4,931.2 per share, with any remaining sale proceeds to be delivered to him.

Positive

  • None.

Negative

  • None.
Insider Iijima Masami
Role null
Type Security Shares Price Value
Disposition Tax Obligation Award 2,152 $4,931.20 $10.61M
Grant/Award Tax Obligation Award 1,937 $0.00 --
Grant/Award Ordinary Shares 1,800 $0.00 --
Holdings After Transaction: Tax Obligation Award — 0 shares (Direct, null); Ordinary Shares — 14,601 shares (Direct, null)
Footnotes (1)
  1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029. Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10. The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
RSU share grant 1,800 shares Ordinary Shares awarded on July 1, 2026
Tax Obligation Awards granted 1,937 units Awards tied to Ordinary Shares on July 1, 2026
Tax Obligation Awards disposed 2,152 units Disposition to issuer on July 10, 2026
Weighted average sale price JPY 4,931.2 per share Sales within JPY 4,883–5,045 range
Shares held after grant 14,601 shares Direct Ordinary Share holdings after July 1, 2026
RSU vesting date June 1, 2029 Vesting date for 1,800 RSUs
restricted stock units (RSUs) financial
"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Tax Obligation Award financial
"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations."
weighted average price financial
"The price reported in Column 8 is a weighted average price denominated in Yen."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Ordinary Shares financial
"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment."
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
contingent right financial
"Each RSU represents a contingent right to receive one share of Common Stock."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Takeda (TAK) director Masami Iijima report in this Form 4 filing?
Masami Iijima reported equity compensation activity, including a grant of 1,800 Takeda Ordinary Shares and 1,937 Tax Obligation Awards, plus a disposition of 2,152 Tax Obligation Awards linked to previously vested shares, all as part of standard compensation and tax management arrangements.

How many Takeda (TAK) shares does Masami Iijima hold after these transactions?
Following the July 1 grant, Masami Iijima directly holds 14,601 Takeda Ordinary Shares. This figure reflects his updated ownership after receiving 1,800 shares as a restricted stock unit award, as disclosed in the Form 4 insider transaction report for the director.

What are the key details of Masami Iijima’s restricted stock unit grant at Takeda (TAK)?
Masami Iijima received an award of 1,800 restricted stock units, each representing one Takeda Ordinary Share. The RSUs vest on June 1, 2029, meaning he will receive the underlying shares at that time if vesting conditions are satisfied, subject to standard plan terms.

What is a Tax Obligation Award in the context of Takeda (TAK) insider filings?
A Tax Obligation Award is economically equivalent to one Takeda Ordinary Share but is settled in cash at vesting, primarily to cover tax obligations. The cash amount is based on the then-current market price, with any remaining proceeds after taxes delivered to the reporting person.

What happened with the 2,152 Tax Obligation Awards reported by Masami Iijima at Takeda (TAK)?
Masami Iijima disposed of 2,152 Tax Obligation Awards to the issuer on July 10. The associated Ordinary Shares were sold at a weighted average price of JPY 4,931.2, primarily to fund tax obligations, with any remaining proceeds to be paid to him on July 10.

How many new Tax Obligation Awards did Masami Iijima receive from Takeda (TAK)?
On July 1, Masami Iijima received 1,937 Tax Obligation Awards tied to Takeda Ordinary Shares. Each represents the economic value of one share and will be converted into a cash payment at vesting, mainly to satisfy tax liabilities at the then-current share price.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Iijima Masami
(Last)(First)(Middle)
2-1, OTEMACHI 1-CHOME
CHIYODA-KU
(Street)
TOKYO100-8631
(City)(State)(Zip)
JAPAN
(Country)		2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/01/2026A(1)1,800A$014,601D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Tax Obligation Award(2)07/10/2026(2)D2,15206/01/202606/01/2026Ordinary Shares2,152$4,931.2(3)0D
Tax Obligation Award(4)07/01/2026A1,93706/01/202906/01/2029Ordinary Shares1,937$01,937D
Explanation of Responses:
1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029.
2. Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10.
3. The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Remarks:
/s/ Samuel Ntonme, by power of attorney, for Masami Iijima07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR